Found: 28
Select item for more details and to access through your institution.
News and Views November 2019.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2582, doi. 10.1111/dom.13883
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2581, doi. 10.1111/dom.13880
- Publication type:
- Article
GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2576, doi. 10.1111/dom.13847
- By:
- Publication type:
- Article
Effect of once‐weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD‐2 clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2570, doi. 10.1111/dom.13844
- By:
- Publication type:
- Article
A novel specific peroxisome proliferator‐activated receptor γ (PPARγ) modulator YR4‐42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet‐induced obese mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2553, doi. 10.1111/dom.13843
- By:
- Publication type:
- Article
Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2564, doi. 10.1111/dom.13841
- By:
- Publication type:
- Article
Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2505, doi. 10.1111/dom.13835
- By:
- Publication type:
- Article
Glucagon‐like peptide‐2 mobilizes lipids from the intestine by a systemic nitric oxide‐independent mechanism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2535, doi. 10.1111/dom.13839
- By:
- Publication type:
- Article
Prevention of type 2 diabetes in prediabetic patients by using functional olive oil enriched in oleanolic acid: The PREDIABOLE study, a randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2526, doi. 10.1111/dom.13838
- By:
- Publication type:
- Article
An evidence‐based approach to developing low‐carbohydrate diets for type 2 diabetes management: A systematic review of interventions and methods.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2513, doi. 10.1111/dom.13837
- By:
- Publication type:
- Article
Fixed versus flexible combination of GLP‐1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2542, doi. 10.1111/dom.13840
- By:
- Publication type:
- Article
A 96‐week, multinational, randomized, double‐blind, parallel‐group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2496, doi. 10.1111/dom.13833
- By:
- Publication type:
- Article
Early hypoglycaemia and adherence after basal insulin initiation in a nationally representative sample of Medicare beneficiaries with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2486, doi. 10.1111/dom.13832
- By:
- Publication type:
- Article
Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2368, doi. 10.1111/dom.13831
- By:
- Publication type:
- Article
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second‐line therapy: Results from the global DISCOVER study programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2474, doi. 10.1111/dom.13830
- By:
- Publication type:
- Article
Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2465, doi. 10.1111/dom.13829
- By:
- Publication type:
- Article
Longer‐term liraglutide administration at the highest dose approved for obesity increases reward‐related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti‐obesity therapies
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2459, doi. 10.1111/dom.13827
- By:
- Publication type:
- Article
Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2450, doi. 10.1111/dom.13826
- By:
- Publication type:
- Article
Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2440, doi. 10.1111/dom.13825
- By:
- Publication type:
- Article
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2429, doi. 10.1111/dom.13824
- By:
- Publication type:
- Article
Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2422, doi. 10.1111/dom.13823
- By:
- Publication type:
- Article
Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self‐titrating insulin glargine U‐100.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2413, doi. 10.1111/dom.13822
- By:
- Publication type:
- Article
Impact of achieving primary care targets in type 2 diabetes on health outcomes and healthcare costs.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2405, doi. 10.1111/dom.13821
- By:
- Publication type:
- Article
Type 2 diabetes treatment and outcomes worldwide: A short review of the DISCOVER study programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2349, doi. 10.1111/dom.13817
- By:
- Publication type:
- Article
Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2354, doi. 10.1111/dom.13819
- By:
- Publication type:
- Article
Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2384, doi. 10.1111/dom.13818
- By:
- Publication type:
- Article
Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2394, doi. 10.1111/dom.13820
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2347, doi. 10.1111/dom.13435
- Publication type:
- Article